Mcl-1 as well as Bok transmembrane domain names: Unpredicted participants in the modulation associated with Navitoclax inhibitor
Navitoclax is an experimental orally active anti-cancer drug.
Language: English
Dove Press is a member of the Open Access Initiative, specializing in peer reviewed Medical Journals. View articles or submit your research for publishing.
An antibody shouldn't be one of the variables in your experiment. Find out why customers rank CST highest for antibody specificity and sensitivity.
OncoLink, the Web's first cancer resource, provides comprehensive information on coping with cancer, cancer treatments, cancer research advances, continuing medical education, cancer prevention, and clinical trials